Butterfly Network, Inc. — Director's Dealing 2022

Mar 5, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Butterfly Network, Inc. (BFLY)
CIK: 0001804176
Period of Report: 2022-02-24

Reporting Person: Martin John David (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	38936	Direct
Class A Common Stock	7977	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.77	2027-07-11	Class A Common Stock (519150)		Direct
Stock Option (right to buy)	$9.40	2030-12-17	Class A Common Stock (41532)		Direct
Stock Option (right to buy)	$9.40	2030-12-17	Class A Common Stock (62298)		Direct

Footnotes

F1: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in equal annual installments over four years beginning on February 11, 2022, subject to Dr. Martin's continued service through the applicable vesting date. In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of November 19, 2020, by and among Longview Acquisition Corp. ("Longview"), Clay Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Longview ("Merger Sub"), and Butterfly Network, Inc., a Delaware corporation ("Butterfly"), pursuant to which Merger Sub merged with and into Butterfly (the "Merger"), with Butterfly surviving as a wholly-owned subsidiary of Longview (which changed its name to "Butterfly Network, Inc.", the "Issuer"), these shares were received in exchange for 50,000 RSUs of Butterfly.

F2: The shares underlying this option are fully vested.

F3: Received in connection with the Merger in exchange for a stock option to acquire 500,000 shares of Butterfly common stock for $1.83 per share.

F4: The shares underlying this option vest in equal monthly installments over 48 months beginning on January 31, 2021, subject to Dr. Martin's continued service through the applicable vesting date.

F5: Received in connection with the Merger in exchange for a stock option to acquire 40,000 shares of Butterfly common stock for $9.75 per share.

F6: The shares underlying this option vest in equal monthly installments over 48 months beginning on January 31, 2021, subject to Dr. Martin's continued service through the applicable vesting date.

F7: Received in connection with the Merger in exchange for a stock option to acquire 60,000 shares of Butterfly common stock for $9.75 per share.